AKT1 and Alzheimer disease: Our results further elucidated potential molecular mechanisms by which FGF10 exerts its protective effects and suggested that regulation of the FGFR2/PI3K/AKT pathway may be a potential target mediating the beneficial effects of FGF10 on AD‐like symptoms and pathologies (Figure 7l).